Diagnosis of Atrial Fibrillation Using Machine Learning With Wearable Devices After Cardiac Surgery: Algorithm Development Study.

Apple Watch algorithm atrial fibrillation cardiac surgery cardiology detection development diagnose heart mHealth machine learning mobile health photoplethysmography pilot study pulse sensor wearable device

Journal

JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394

Informations de publication

Date de publication:
01 Aug 2022
Historique:
received: 02 12 2021
accepted: 13 06 2022
revised: 07 06 2022
entrez: 2 8 2022
pubmed: 3 8 2022
medline: 3 8 2022
Statut: epublish

Résumé

Some attempts have been made to detect atrial fibrillation (AF) with a wearable device equipped with photoelectric volumetric pulse wave technology, and it is expected to be applied under real clinical conditions. This study is the second part of a 2-phase study aimed at developing a method for immediate detection of paroxysmal AF, using a wearable device with built-in photoplethysmography (PPG). The objective of this study is to develop an algorithm to immediately diagnose AF by an Apple Watch equipped with a PPG sensor that is worn by patients undergoing cardiac surgery and to use machine learning on the pulse data output from the device. A total of 80 patients who underwent cardiac surgery at a single institution between June 2020 and March 2021 were monitored for postoperative AF, using a telemetry-monitored electrocardiogram (ECG) and an Apple Watch. AF was diagnosed by qualified physicians from telemetry-monitored ECGs and 12-lead ECGs; a diagnostic algorithm was developed using machine learning on the pulse rate data output from the Apple Watch. One of the 80 patients was excluded from the analysis due to redness caused by wearing the Apple Watch. Of 79 patients, 27 (34.2%) developed AF, and 199 events of AF including brief AF were observed. Of them, 18 events of AF lasting longer than 1 hour were observed, and cross-correlation analysis showed that pulse rate measured by Apple Watch was strongly correlated (cross-correlation functions [CCF]: 0.6-0.8) with 8 events and very strongly correlated (CCF>0.8) with 3 events. The diagnostic accuracy by machine learning was 0.9416 (sensitivity 0.909 and specificity 0.838 at the point closest to the top left) for the area under the receiver operating characteristic curve. We were able to safely monitor pulse rate in patients who wore an Apple Watch after cardiac surgery. Although the pulse rate measured by the PPG sensor does not follow the heart rate recorded by telemetry-monitored ECGs in some parts, which may reduce the accuracy of AF diagnosis by machine learning, we have shown the possibility of clinical application of using only the pulse rate collected by the PPG sensor for the early detection of AF.

Sections du résumé

BACKGROUND BACKGROUND
Some attempts have been made to detect atrial fibrillation (AF) with a wearable device equipped with photoelectric volumetric pulse wave technology, and it is expected to be applied under real clinical conditions.
OBJECTIVE OBJECTIVE
This study is the second part of a 2-phase study aimed at developing a method for immediate detection of paroxysmal AF, using a wearable device with built-in photoplethysmography (PPG). The objective of this study is to develop an algorithm to immediately diagnose AF by an Apple Watch equipped with a PPG sensor that is worn by patients undergoing cardiac surgery and to use machine learning on the pulse data output from the device.
METHODS METHODS
A total of 80 patients who underwent cardiac surgery at a single institution between June 2020 and March 2021 were monitored for postoperative AF, using a telemetry-monitored electrocardiogram (ECG) and an Apple Watch. AF was diagnosed by qualified physicians from telemetry-monitored ECGs and 12-lead ECGs; a diagnostic algorithm was developed using machine learning on the pulse rate data output from the Apple Watch.
RESULTS RESULTS
One of the 80 patients was excluded from the analysis due to redness caused by wearing the Apple Watch. Of 79 patients, 27 (34.2%) developed AF, and 199 events of AF including brief AF were observed. Of them, 18 events of AF lasting longer than 1 hour were observed, and cross-correlation analysis showed that pulse rate measured by Apple Watch was strongly correlated (cross-correlation functions [CCF]: 0.6-0.8) with 8 events and very strongly correlated (CCF>0.8) with 3 events. The diagnostic accuracy by machine learning was 0.9416 (sensitivity 0.909 and specificity 0.838 at the point closest to the top left) for the area under the receiver operating characteristic curve.
CONCLUSIONS CONCLUSIONS
We were able to safely monitor pulse rate in patients who wore an Apple Watch after cardiac surgery. Although the pulse rate measured by the PPG sensor does not follow the heart rate recorded by telemetry-monitored ECGs in some parts, which may reduce the accuracy of AF diagnosis by machine learning, we have shown the possibility of clinical application of using only the pulse rate collected by the PPG sensor for the early detection of AF.

Identifiants

pubmed: 35916709
pii: v6i8e35396
doi: 10.2196/35396
pmc: PMC9379796
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e35396

Informations de copyright

©Daisuke Hiraoka, Tomohiko Inui, Eiryo Kawakami, Megumi Oya, Ayumu Tsuji, Koya Honma, Yohei Kawasaki, Yoshihito Ozawa, Yuki Shiko, Hideki Ueda, Hiroki Kohno, Kaoru Matsuura, Michiko Watanabe, Yasunori Yakita, Goro Matsumiya. Originally published in JMIR Formative Research (https://formative.jmir.org), 01.08.2022.

Références

Heart Rhythm O2. 2020 Apr 27;1(1):3-9
pubmed: 34113853
J Am Coll Cardiol. 1997 Oct;30(4):1039-45
pubmed: 9316536
Heart Rhythm. 2020 May;17(5 Pt B):847-853
pubmed: 32354449
Eur Heart J. 2009 Dec;30(24):2969-77c
pubmed: 19535417
Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e006834
pubmed: 31113234
Physiol Meas. 2018 Jun 27;39(6):065007
pubmed: 29856730
N Engl J Med. 2012 Jan 12;366(2):120-9
pubmed: 22236222
Circ J. 2012;76(4):1020-3
pubmed: 22451452
Int J Cardiol. 2020 Feb 1;300:161-164
pubmed: 31787389
JMIR Cardio. 2020 Jan 22;4(1):e14857
pubmed: 32012044
Circulation. 2019 Dec 17;140(25):e944-e963
pubmed: 31694402
Circulation. 2004 Aug 31;110(9):1042-6
pubmed: 15313941
Lancet Neurol. 2015 Apr;14(4):377-87
pubmed: 25748102
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76
pubmed: 24685669
Front Physiol. 2021 Feb 18;12:637680
pubmed: 33679450
N Engl J Med. 2019 Nov 14;381(20):1909-1917
pubmed: 31722151
Circulation. 1973 Feb;47(2):399-407
pubmed: 4567870
JAMA Cardiol. 2018 May 1;3(5):409-416
pubmed: 29562087
Stroke. 2014 Sep;45(9):2599-605
pubmed: 25034713
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Cerebrovasc Dis. 2010;29(1):43-9
pubmed: 19893311
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Br Heart J. 1990 Mar;63(3):157-61
pubmed: 2183858
J Nutr Sci Vitaminol (Tokyo). 2016;62(6):432-436
pubmed: 28202849

Auteurs

Daisuke Hiraoka (D)

Department of Cardiovascular Surgery, University of Chiba, Chiba, Japan.

Tomohiko Inui (T)

Department of Cardiovascular Surgery, University of Chiba, Chiba, Japan.

Eiryo Kawakami (E)

Department of Artificial Intelligence Medicine, Graduate School of Medicine, University of Chiba, Chiba, Japan.
RIKEN Information R&D and Strategy Headquarters, Yokohama, Japan.

Megumi Oya (M)

Department of Artificial Intelligence Medicine, Graduate School of Medicine, University of Chiba, Chiba, Japan.
RIKEN Information R&D and Strategy Headquarters, Yokohama, Japan.

Ayumu Tsuji (A)

Department of Artificial Intelligence Medicine, Graduate School of Medicine, University of Chiba, Chiba, Japan.

Koya Honma (K)

Department of Artificial Intelligence Medicine, Graduate School of Medicine, University of Chiba, Chiba, Japan.

Yohei Kawasaki (Y)

Clinical Research Center, University of Chiba, Chiba, Japan.

Yoshihito Ozawa (Y)

Clinical Research Center, University of Chiba, Chiba, Japan.

Yuki Shiko (Y)

Clinical Research Center, University of Chiba, Chiba, Japan.

Hideki Ueda (H)

Department of Cardiovascular Surgery, University of Chiba, Chiba, Japan.

Hiroki Kohno (H)

Department of Cardiovascular Surgery, University of Chiba, Chiba, Japan.

Kaoru Matsuura (K)

Department of Cardiovascular Surgery, University of Chiba, Chiba, Japan.

Michiko Watanabe (M)

Department of Cardiovascular Surgery, University of Chiba, Chiba, Japan.

Yasunori Yakita (Y)

Department of Cardiovascular Surgery, University of Chiba, Chiba, Japan.

Goro Matsumiya (G)

Department of Cardiovascular Surgery, University of Chiba, Chiba, Japan.

Classifications MeSH